Sprott Inc. Amgen Inc Transaction History

Sprott Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$197.81 - $242.74 $2.97 Million - $3.64 Million	-15,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$189.21 - $243.2 $1.89 Million - $2.43 Million	10,000 Added 200.0%	15,000 $3.62 Million
Q1 2019 May 15, 2019	SELL	$180.87 - $203.88 $904,350 - $1.02 Million	-5,000 Reduced 50.0%	5,000 $949,000
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $2.53 Million - $2.96 Million	-14,200 Reduced 58.68%	10,000 $1.95 Million
Q3 2018 Nov 14, 2018	SELL	$185.29 - $208.89 $55,587 - $62,666	-300 Reduced 1.22%	24,200 $5.02 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $913,275 - $1.03 Million	5,500 Added 28.95%	24,500 $4.52 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $1.12 Million - $1.31 Million	-6,600 Reduced 25.78%	19,000 $0
Q3 2017 Nov 03, 2017	BUY	$167.29 - $191.0 $4.28 Million - $4.89 Million	25,600	25,600 $4.77 Million

3,125

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Sprott Inc., based on Form 13F filings with the SEC.

Stay updated on Sprott Inc. with notifications on news.